Italfarmaco, one of the leading Italian pharmaceutical groups, operates in both the pharmaceutical and the fine chemical industries.
The company was founded in Milan in 1938.
The Italfarmaco Group now markets ethical products in Italy, Switzerland, Spain, Portugal, Greece, Russia, Turkey, Chile, Peru, Morocco and also for the subsidiary Chemi SPA in USA and Brazil. Total employees is over 2100 and total turnover exceeds 500 million euros.
Its products, all of which have a high therapeutic content, are mainly used in the cardiovascular, immuno-oncological, gynaecological, dermatological, orthopaedic and neurological areas.
The group owns modern, sophisticated industrial plants at which it manufactures its proprietary drugs to the highest quality standards. The first plant, at which injectables and solid oral drugs are manufactured, is situated in Milan, and a second manufacturing unit, for the production of liquid oral drugs, is located in Madrid.
Chemical-pharmaceutical products are manufactured in the industrial plants located in Frosinone (Italy) and Camaçari (Brazil).
The Italfarmaco Group is particularly active in the field of research, mainly oriented towards the cardiovascular area and diseases associated with alterations of the immunological system.
Product portfoglio expansion of the entire group and consolidation in international markets represents priority objectives.
Product portfoglio expansion is pursued through:
- increased investments in R&D in order to develop innovative products in already established therapeutic areas;
- commercial partnerships with pharmaceutical companies in the field of therapeutic areas with an established presence.
Further expansion in Europe and foundation of new affiliates in foreign markets represent the goal which the company pursues through the creation of new subsidiaries and joint ventures with other pharmaceutical firms.
In addition to its pharmaceutical activities in the field of ethical drugs, the Group markets through the company Lifepharma on foreign markets such as Russia and the Middle East with its own offices and sales network.
In addition to research, production and marketing of drugs, the Italfarmaco Group manufactures active ingredients for the pharmaceutical industry through its subsidiary Chemi S.p.A. and Italfarmaco Chemical (Brazil) which represent the Group’s chemical-industry arm.
Chemi S.p.A. sells some 90% of its products on foreign markets (USA, Japan, EU, etc.), on which it collaborates with many international pharmaceutical companies.
Chemi S.p.A. is among the leading manufacturers of active ingredients, and owns advanced technologies in the field of phospholipids, peptides and the chemistry of chiral products.
Click here for in-depth information about the company’s international growth since 1991.